Cargando…
Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia
The natural history of severe hemoglobinopathies like sickle cell disease (SCD) is rather variable, depending on the circumstances, but the main influence on such variability is the level of fetal hemoglobin (HbF) in the patient’s red cells. It is well known that a significant HbF level is associate...
Autores principales: | Eridani, Sandro, Mosca, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262355/ https://www.ncbi.nlm.nih.gov/pubmed/22287860 http://dx.doi.org/10.2147/JBM.S14942 |
Ejemplares similares
-
Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015) -
Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia—Current Status and Perspectives in Fetal Hemoglobin Reactivation
por: Ng, Noel Yat Hey, et al.
Publicado: (2014) -
Sickle cell protection from malaria
por: Eridani, Sandro
Publicado: (2011) -
Genome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania
por: Mtatiro, Siana Nkya, et al.
Publicado: (2014) -
Sickle Cell Disease and Fetal Hemoglobin
por: Rivera, Alicia
Publicado: (2018)